Sprache auswählen

Kostenlose Registrierung

Quote Inquiry/Quick Order

Mein Warenkorb

G4S

Produktanfrage

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Zibotentan/Dapagliflozin		Phase 3 Clinical	Astrazeneca Ab, AstraZeneca global R & D (China) Co Ltd	Albuminuria; Kidney Diseases; Renal Insufficiency, Chronic	Details
Patecibart	GMA-301; GMA-301-A; GMA-301-B	Phase 2 Clinical	Gmax Biopharm Llc	Pulmonary Arterial Hypertension	Details
SC-0062	SC-0062	Phase 2 Clinical	Shijiazhuang Zhikang Hongren New Drug Development Co Ltd	Glomerulonephritis, IGA; Altitude Sickness; Kidney Diseases; Pulmonary Arterial Hypertension; Diabetic Nephropathies	Details
Zibotentan	ZD-4054; AZD-4054	Phase 2 Clinical	Astrazeneca Plc	Hepatic Insufficiency; Scleroderma, Limited; Neoplasm Metastasis; Peripheral Arterial Disease; Carcinoma, Non-Small-Cell Lung; Metastatic breast cancer; Renal Insufficiency, Chronic; Lung Neoplasms; Colorectal Neoplasms; Solid tumours; Prostatic Neoplasms; Hypertension, Portal; Scleroderma, Systemic; Liver Cirrhosis; Intermittent Claudication; Renal Insufficiency; Ovarian Neoplasms; Microvascular Angina	Details
BQ-123	CGS-26343; BQ-123; PMZ-2123	Phase 1 Clinical	Midwestern University	Hypertension, Pulmonary; Heart Failure; ST Elevation Myocardial Infarction; Pain; Diabetic Ketoacidosis; Coronary Artery Disease; Proteinuria; Metabolic Syndrome; Hypoxia, Brain; Hypertension; Cardiovascular Diseases; Renal Insufficiency, Chronic; Multiple System Atrophy; Pure Autonomic Failure	Details
GMA-131	GMA-131	Phase 1 Clinical	Gmax Biopharm Llc, Gmaxx Biologics Ltd	Diabetic Nephropathies	Details
SAL-0120	SAL0120; SAL-0120	Phase 1 Clinical	Shenzhen Salubris Pharmaceuticals Co Ltd	Glomerulonephritis, IGA; Hypertension; Essential Hypertension	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Clazosentan Sodium	Ro-61-1790; ACT-108475; AXV-034; VML-588; AXV-034343	Approved	F. Hoffmann-La Roche Ltd	Pivlaz	Japan	Subarachnoid Hemorrhage; Vasospasm, Intracranial; Cerebral Infarction; Brain Ischemia	Idorsia Pharmaceuticals Ltd	2022-01-20	Brain Ischemia; Aneurysm; Vasospasm, Intracranial; Subarachnoid Hemorrhage; Cerebral Infarction	Details
Macitentan/Tadalafil		Approved	Actelion Pharmaceuticals Ltd	OPSYNVI	United States	Pulmonary Arterial Hypertension	Actelion Pharmaceuticals Us Inc	2024-03-22	Pulmonary Arterial Hypertension	Details
Ambrisentan	LU-208075; BSF-208075; GSK-132576A	Approved	Abbott Laboratories	Letairis, Volibris, 凡瑞克	United States	Pulmonary Arterial Hypertension	Gilead Sciences Inc	2007-06-15	Hypertension, Pulmonary; Sarcoidosis; Hypertension, Portal; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Thromboembolism; Hypertension; Ascites; Hypoxia; Acute Kidney Injury; Pulmonary Arterial Hypertension; Vascular Diseases; Anemia, Sickle Cell; Hepatorenal Syndrome	Details
Sparsentan	RE-021; PS-433540; BMS-346567	Approved	Bristol-Myers Squibb Company	Filspari	United States	Glomerulonephritis, IGA	Travere Therapeutics Inc	2023-02-17	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Vasculitis; Autoimmune Diseases; Nephrosis, Lipoid; Hypertension; Immune System Diseases; Glomerulosclerosis, Focal Segmental; Cardiovascular Diseases; Nephritis, Hereditary; Glomerulonephritis	Details
Bosentan Hydrate	ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039	Approved	F. Hoffmann-La Roche Ltd	Stayveer, 全可利, Tracleer	United States	Pulmonary Arterial Hypertension	Actelion Pharmaceuticals Ltd	2001-11-20	Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial	Details
Macitentan	ACT-064992; Actelion-1; JNJ-67896062	Approved	Actelion Pharmaceuticals Ltd	Zependo, Opsumit, 傲朴舒	United States	Pulmonary Arterial Hypertension	Actelion Pharmaceuticals Us Inc	2013-10-18	Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease	Details
Aprocitentan	ACT-132577; AC-080; JNJ-2820	Approved	Idorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals Ltd	TRYVIO	United States	Hypertension	Idorsia Pharmaceuticals Ltd	2024-03-19	Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic	Details

Produktanfrage
Inverkehr gebrachte Arzneimittelinformation
Klinische Arzneimittelinformation

Website-Feedback

Kontaktieren Sie uns

+49 800 0826645

order.de@acrobiosystems.com
tech.de@acrobiosystems.com

BettinastraBe 30, 60325 Frankfurt am Main